{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:26:00Z","timestamp":1792167960581,"version":"4.4.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background and objective<\/jats:title><jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has broad tissue tropism and high transmission, which are likely to perpetuate the pandemic. The study aim to analyze the clinicopathogenic characteristics in paediatric patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this single-centre study, we retrospectively included all confirmed cases infected by SARS-CoV-2 infection at Xi\u2019an Children's Hospital, China, from 1 December to 31 December 2022. The demographic, clinical, laboratory, and radiological features of the patients were analysed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 4,520 paediatric patients with SARS-CoV-2 omicron variant infections were included. Of these, 3,861 (85.36%) were outpatients, 659 (14.64%) were hospitalised patients, and nine patients (0.20%) died. Of the nine patients who died, five were diagnosed with acute necrotising encephalopathy (ANE). The most common symptoms were fever in 4,275 (94.59%) patients, cough in 1,320 (29.20%) patients, convulsions in 610 (13.50%) patients, vomiting in 410 (9.07%) patients, runny nose\/coryza in 277 (6.13%) patients, hoarseness of voice in 273 (6.04%) patients. A blood cell analysis showed a slight elevation of monocytes (mean: 11.14\u2009\u00b1\u20090.07%). The main diagnoses for both outpatients and inpatients were respiratory infection with multisystem manifestations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A high incidence of convulsions is a typical characteristic of children infected with SARS-CoV-2. Five of the nine COVID-19 fatalities were associated with ANE. This indicates that nervous system damage in children with SARS-CoV-2 infection is more significant.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2024.1325562","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T04:29:11Z","timestamp":1708662551000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical characteristics of 4,520 paediatric patients infected with the SARS-CoV-2 omicron variant, in Xi'an, China"],"prefix":"10.3389","volume":"12","author":[{"given":"Jingwei","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"8012","DOI":"10.26355\/eurrev_202112_27652","article-title":"Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics","volume":"25","author":"Meo","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B3","year":""},{"key":"B4","doi-asserted-by":"publisher","first-page":"e685","DOI":"10.1002\/ctm2.685","article-title":"The omicron variant of SARS-CoV-2: understanding the known and living with unknowns","volume":"11","author":"Ingraham","year":"2021","journal-title":"Clin Transl Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","article-title":"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"B6","year":""},{"key":"B7","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-CoV-2 transmission and pathogenesis","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"B11","year":""},{"key":"B12","doi-asserted-by":"publisher","first-page":"e13845","DOI":"10.1111\/eci.13845","article-title":"Risk of reinfection and disease after SARS-CoV-2 primary infection: meta-analysis","volume":"52","author":"Flacco","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"B13","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1080\/22221751.2022.2052358","article-title":"SARS-CoV-2 reinfection and COVID-19 severity","volume":"11","author":"Nguyen","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"B14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1128\/JVI.01702-06","article-title":"Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 virus receptor","volume":"81","author":"Tseng","year":"2007","journal-title":"J Virol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","article-title":"SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function","volume":"21","author":"Winkler","year":"2020","journal-title":"Nat Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1128\/JVI.00737-08","article-title":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2","volume":"82","author":"Netland","year":"2008","journal-title":"J Virol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","article-title":"SARS-CoV-2 infection and persistence in the human body and brain at autopsy","volume":"612","author":"Stein","year":"2022","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"789180","DOI":"10.3389\/fcimb.2021.789180","article-title":"ACE2 Shedding and the role in COVID-19","volume":"11","author":"Wang","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/14737175.2023.2224503","article-title":"Pathogenesis and management of acute necrotizing encephalopathy","volume":"23","author":"Qin","year":"2023","journal-title":"Expert Rev Neurother"},{"key":"B22","doi-asserted-by":"publisher","first-page":"ofv013","DOI":"10.1093\/ofid\/ofv013","article-title":"Only a touch of the flu? The simultaneous manifestation of acute necrotizing encephalopathy in two consanguineous patients","volume":"2","author":"Bloch","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/jdn.10201","article-title":"Clinical features and imaging manifestations of acute necrotizing encephalopathy in children","volume":"82","author":"Wu","year":"2022","journal-title":"Int J Dev Neurosci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"102194","DOI":"10.1016\/j.msard.2020.102194","article-title":"Genetic acute necrotizing encephalopathy associated with RANBP2: clinical and therapeutic implications in pediatrics","volume":"43","author":"Levine","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"B25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/path.5471","article-title":"Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)","volume":"251","author":"Bourgonje","year":"2020","journal-title":"J Pathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"594495","DOI":"10.3389\/fmed.2020.594495","article-title":"Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2","volume":"7","author":"Salamanna","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e2112131","DOI":"10.1001\/jamanetworkopen.2021.12131","article-title":"Global incidence of neurological manifestations among patients hospitalized with COVID-19-A report for the GCS-NeuroCOVID consortium and the ENERGY consortium","volume":"4","author":"Chou","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B28","doi-asserted-by":"publisher","first-page":"105921","DOI":"10.1016\/j.clineuro.2020.105921","article-title":"Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review","volume":"194","author":"Montalvan","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neurop.2021.12.003","article-title":"Neurological symptoms associated with SARS-CoV-2 infection in a tertiary hospital in bogota","volume":"2","author":"Zapa-P\u00e9rez","year":"2022","journal-title":"Colombia. Neurol Perspect"},{"key":"B30","doi-asserted-by":"publisher","first-page":"586","DOI":"10.12116\/j.issn.1004-5619.2023.430703","article-title":"Pathological changes and cause of death associated with the global novel coronavirus disease (COVID-19)","volume":"39","author":"Yang","year":"2023","journal-title":"Fa Yi Xue Za Zhi"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1007\/s11596-023-2797-3","article-title":"Clinical characteristics, diagnosis, and therapeutics of COVID-19: a review","volume":"43","author":"Xie","year":"2023","journal-title":"Curr Med Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00011-012-0439-5","article-title":"Immune regulation of procalcitonin: a biomarker and mediator of infection","volume":"61","author":"Matwiyoff","year":"2012","journal-title":"Inflamm Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11908-022-00779-0","article-title":"COVID-19 Infection in children: diagnosis and management","volume":"24","author":"Zhu","year":"2022","journal-title":"Curr Infect Dis Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.3346\/jkms.2023.38.e65","article-title":"Clinical characteristics and outcomes of children with SARS-CoV-2 infection during the Delta and omicron variant-dominant periods in Korea","volume":"38","author":"Choi","year":"2023","journal-title":"J Korean Med Sci"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1325562\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T04:29:15Z","timestamp":1708662555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1325562\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":34,"alternative-id":["10.3389\/fped.2024.1325562"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1325562","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]},"article-number":"1325562"}}